C12N 2795/18022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/18022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 7 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 22
- Assignees
- 14
- Inventors
- 34
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 3 | 1 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 3 |
| 2026 | 2 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for microbial delivery of double stranded RNA28 Jul 2026US 12,690,596 B2Rnaissance AG LLC
- Compositions and methods for controlled mRNA translation and stability3 Mar 2026US 12,565,665 B2Trustees of Boston University
- Method for constructing functional exosomes capable of efficiently loading specific miRNA12 Sep 2023US 11,753,621 B2Chinese Pla General Hospital
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents11 Dec 2018US 10,151,762 B2Proclara Biosciences, Inc.
- Scalable fermentation process13 Dec 2016US 9,518,095 B2Kuros Biosciences AG
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Method for controlling intracellular localization of sgrna and regulating gene expression24 Sep 2026US 2026/0286351 A1Guangzhou Medical University
- System for regulating protein translation13 Aug 2026US 2026/0234645 A1National University Corporation Tokyo Medical and Dental University
- Compositions and methods for controlled mrna translation and stability25 Jun 2026US 2026/0176653 A1Trustees of Boston University
- Scalable fermentation process30 Oct 2025US 2025/0333449 A1Kuros Biosciences AG
Most cited
By later US patents
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents7US 9,493,515 B2Proclara Biosciences, Inc. · 2016
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents5US 9,493,516 B2Proclara Biosciences, Inc. · 2016
- Scalable fermentation process4US 9,518,095 B2Kuros Biosciences AG · 2016